Related Experiment Video
Updated: Aug 2, 2026

A Novel Approach for the Administration of Medications and Fluids in Emergency Scenarios and Settings
Published on: November 9, 2016
[Urapidil (Ebrantil) use in patients on chronic hemodialysis]
1Ośrodka Dializ przy Oddziale Chorób Wewnetrznych.
Abstract:
In 10 patients on chronic haemodialysis treatment for terminal renal failure with hypertension urapidil (Ebrantil) was given in one daily dose of 30 mg, usually continuing the previously used antihypertensive drugs. A significant decrease of the systolic and diastolic arterial blood pressure was achieved in most cases. Full therapeutic effect was manifested after several weeks of drug administration. During the treatment no tendency was noted for orthostatic hypotension, and no other side effects were observed. It seems that urapidil may be useful in the treatment of hypertension in dialysed patients. The usefulness of the drug in monotherapy requires further studies.
Related Concept Videos
Dialysis
Acute kidney injury develops suddenly and can be caused by pre-renal causes (e.g., hypovolemia, shock), intrinsic renal causes (e.g., acute tubular necrosis), or post-renal causes (e.g., urinary obstruction). In contrast, chronic renal failure progresses gradually over time and is often...
Extracorporeal Removal of Drugs: Peritoneal Dialysis and Hemodialysis
Peritoneal Dialysis II: Peritoneal Dialysis Systems and Complications
Hemodialysis I: Introduction
Hemodialysis II: Procedure and Complications
Hemodialysis III: Nursing Management

